Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care.